By Leslie Cohen, Psychedelic Guide
When someone is living with a life limiting or terminal diagnosis, the fear isn’t only about pain or physical decline. What often weighs heaviest is emotional and existential: Why is this happening to me? What happens next? How do I enjoy life while I’m suffering, while I’m dying? For some, death feels imminent and terrifying. For many, anxiety crowds out the ability to be present—making it hard to talk openly with loved ones or to enjoy the time that remains. People can often feel trapped in looping thoughts about running out of time.
Traditional therapies can help, but they don’t always reach the depth of this kind of fear in ways that provide real relief. In recent years, psychedelic-assisted therapies—including ketamine—have emerged as a potential option for easing end-of-life anxiety when used carefully, thoughtfully and within a broader context of compassionate care.
Growing research supports ketamine for those who are given diagnoses that limit their life span. In a 2024 review that examined nine clinical studies involving more than 600 people with terminal or life-limiting illnesses, researchers found that psychedelic-assisted treatments were associated with substantial reductions in both depression and anxiety compared to standard care or placebo. The improvements were not small or subtle, but large enough to be considered clinically meaningful, suggesting that many participants experienced real relief rather than just marginal change. (https://doi.org/10.1002/14651858.CD015383.pub2)
Importantly, these improvements went beyond mood improvement. Participants also showed less hopelessness and emotional distress, along with greater acceptance of death and a stronger sense of meaning in life. Some studies also noted improvements in spiritual or existential well-being—helping people feel more at peace with uncertainty, their own inner experience, and the possibilities of what comes after death.
Ketamine is widely known as an anesthetic and, more recently, as an effective treatment for treatment resistant depression. In palliative and end-of-life care, however, its usefulness extends beyond symptom control. What makes ketamine unique is not just that it can reduce anxiety quickly, but that it can change how people relate to their fear. Rather than eliminating awareness of death, ketamine often helps loosen the grip of panic and mental looping, allowing people to face reality with greater steadiness and calm.
Existential anxiety can feel relentless. Thoughts and fears can run rampant and feel constant—thoughts about not having enough time left and not having done enough, fears about what is coming and about leaving loved ones. Ketamine appears to quiet the brain systems involved in this kind of repetitive thought patterning, creating a sense of psychological space. Many ketamine clients describe the fear as still present, but no longer overwhelming and all consuming. It’s there—but it no longer fills the whole expanse of emotional space. There is some peace in the quieting of the mind. For many, this shift feels like a gift.
With the support of a skilled guide and provider, people who turn to ketamine for this kind of relief report experiences of deep calm, connection, and insight during and after sessions. Many describe gaining a wider perspective on their life and illness—less consumed by urgency and more able to reflect with clarity. This doesn’t mean ketamine “fixes” grief or sadness. Grief, fear, and uncertainty remain natural responses to dying. Ketamine’s role is not to deny these realities, but to make them more bearable and to create room for gratitude, love and acceptance.
The speed with which ketamine works is also an important benefit. While many conventional antidepressants take weeks to have an impact—time that is especially precious to people with terminal diagnoses—ketamine can reduce severe anxiety and despair within hours or days. That relief can be transformative. It may allow someone to sleep through the night for the first time in weeks, to speak honestly with a loved one, or simply to sit quietly without being overtaken by panic.
Importantly, ketamine is not a standalone solution. Its benefits are strongest when integrated into a broader circle of support that may include palliative care, psychotherapy, spiritual counseling, end-of-life doula care, and open conversations about death. Preparation and integration matter. With the right support, the shifts that occur during psychedelic treatment can translate into greater emotional presence, reduced dread, and a stronger ability to make choices that align with what is most valued.
Ketamine is not appropriate for everyone and must be used under careful medical supervision, particularly in medically fragile patients. Thoughtful screening, clear intentions, and respect for each person’s situation are critical. But when offered responsibly and carefully, it can be a deeply compassionate option for those whose anxiety has become heavily burdensome or unbearable.
Ultimately, ketamine’s promise lies in its ability to offer moments of calm, perspective, and emotional breathing room—enough space to connect, reflect, and feel love. For many, that means less fear and more presence in each moment. It means being able to sit with and appreciate time with loved ones, to look back on one’s life without being overwhelmed by despair, and to face uncertainty with greater tenderness. Ketamine experiences are about supporting dignity, connection, and emotional relief—helping people live more fully in the time they have.
